{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T01:44:37Z","timestamp":1784684677447,"version":"3.55.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health and Care Research Manchester Biomedical Research Centre","award":["NIHR203308"],"award-info":[{"award-number":["NIHR203308"]}]},{"name":"National Institute for Health"},{"name":"Care Research"},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>SSc is disabling. However, the different factors contributing to this disability and how these change over time have been little studied. Our aim was to examine the trajectories over time of the six visual analogue scales (VAS) of the Scleroderma HAQ (SHAQ), associations of disease-related factors with these trajectories, and relationships with overall functional ability.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a retrospective study of data collected prospectively from patients attending a single tertiary centre between 2005 and 2022. VAS (pain, intestinal, breathing, RP, digital ulcers, \u2018overall\u2019) were analysed using linear mixed-effects models, and relationships between the six VAS and functional ability [HAQ Disability Index (HAQ-DI)] and scleroderma functional index (FI) by correlating the average gradients obtained from individual linear regressions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 537 patients with at least two time-points were included, followed for a mean (s.d.) of 6.8 (4.2) years. VAS intestinal scores increased (i.e. worsened) by 0.085 points (95% CI 0.041\u20130.130, P\u2009&amp;lt;\u20090.001) per year, VAS breathing by 0.056 points (95% CI 0.016\u20130.096, P\u2009=\u20090.006) and VAS overall scores by 0.073 points (95% CI 0.032\u20130.114, P\u2009=\u20090.001). The longer the duration between RP onset and SSc diagnosis, the lower the VAS pain and VAS intestinal scores. The odds of having at least one digital ulcer reduced with disease duration, with diffuse cutaneous subtype and with anti-Scl70 positivity. Average gradients for all six VAS scales correlated (albeit variably\/weakly) with HAQ-DI and scleroderma FI gradients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Longitudinal assessment of the six SHAQ VAS, and associations of baseline characteristics with the individual VAS time courses, provide insights into disease trajectory and overall disability.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae667","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T22:33:24Z","timestamp":1733870004000},"page":"2821-2827","source":"Crossref","is-referenced-by-count":5,"title":["Longitudinal trajectories of the Scleroderma Health Assessment Questionnaire (SHAQ) visual analogue scales: a retrospective cohort study"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3361-4909","authenticated-orcid":false,"given":"Michael","family":"Hughes","sequence":"first","affiliation":[{"name":"Northern Care Alliance NHS Foundation Trust, Salford Care Organisation , Salford,","place":["UK"]},{"name":"Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre , Manchester,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Sylvestre","sequence":"additional","affiliation":[{"name":"Centre for Biostatistics, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre , Manchester,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Manning","sequence":"additional","affiliation":[{"name":"Northern Care Alliance NHS Foundation Trust, Salford Care Organisation , Salford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Wragg","sequence":"additional","affiliation":[{"name":"Northern Care Alliance NHS Foundation Trust, Salford Care Organisation , Salford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Mandzuk","sequence":"additional","affiliation":[{"name":"Northern Care Alliance NHS Foundation Trust, Salford Care Organisation , Salford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muditha","family":"Samaranayaka","sequence":"additional","affiliation":[{"name":"Northern Care Alliance NHS Foundation Trust, Salford Care Organisation , Salford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6245-2721","authenticated-orcid":false,"given":"Graham","family":"Dinsdale","sequence":"additional","affiliation":[{"name":"Northern Care Alliance NHS Foundation Trust, Salford Care Organisation , Salford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Vail","sequence":"additional","affiliation":[{"name":"Centre for Biostatistics, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre , Manchester,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4941-7926","authenticated-orcid":false,"given":"Ariane L","family":"Herrick","sequence":"additional","affiliation":[{"name":"Northern Care Alliance NHS Foundation Trust, Salford Care Organisation , Salford,","place":["UK"]},{"name":"Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre , Manchester,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"2025050316133414800_keae667-B1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pathol-011110-130312","article-title":"The pathogenesis of systemic sclerosis","volume":"6","author":"Katsumoto","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"2025050316133414800_keae667-B2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"2025050316133414800_keae667-B3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.12968\/hmed.2019.80.9.530","article-title":"Systemic sclerosis","volume":"80","author":"Hughes","year":"2019","journal-title":"Br J Hosp Med"},{"key":"2025050316133414800_keae667-B4","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/rheumatology\/keq310","article-title":"Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey","volume":"50","author":"Bassel","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2025050316133414800_keae667-B5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/03007995.2021.1992371","article-title":"How do systemic sclerosis manifestations influence patients\u2019 lives? Results from a survey on patients and caregivers","volume":"37","author":"Galetti","year":"2021","journal-title":"Curr Med Res Opin"},{"key":"2025050316133414800_keae667-B6","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/art.1780401110","article-title":"The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time","volume":"40","author":"Steen","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2025050316133414800_keae667-B7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/art.21084","article-title":"The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: an evaluation of their measurement properties","volume":"53","author":"Johnson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2025050316133414800_keae667-B8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-7525-1-20","article-title":"The Stanford Health Assessment Questionnaire: dimensions and practical applications","volume":"1","author":"Bruce","year":"2003","journal-title":"Health Qual Life Outcomes"},{"issue":"Suppl 11","key":"2025050316133414800_keae667-B9","first-page":"S98","article-title":"Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trial","volume":"63","author":"Pope","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025050316133414800_keae667-B10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10067-004-0942-3","article-title":"Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ)","volume":"24","author":"Georges","year":"2005","journal-title":"Clin Rheumatol"},{"key":"2025050316133414800_keae667-B11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10067-013-2370-8","article-title":"Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ)","volume":"33","author":"Rocha","year":"2014","journal-title":"Clin Rheumatol"},{"key":"2025050316133414800_keae667-B12","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s10067-020-05373-0","article-title":"Cultural adaptation and validation of the Systemic Sclerosis Quality of Life questionnaire into Arabic language","volume":"40","author":"Alian","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2025050316133414800_keae667-B13","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/art.10486","article-title":"Measuring disease activity and functional status in patients with scleroderma and Raynaud\u2019s phenomenon","volume":"46","author":"Merkel","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2025050316133414800_keae667-B14","first-page":"79","article-title":"Assessment of functional ability in patients with scleroderma: a proposed new disability assessment instrument","volume":"25","author":"Silman","year":"1998","journal-title":"J Rheumatol"},{"key":"2025050316133414800_keae667-B15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/03009742.2018.1523455","article-title":"Changes in disability and their relationship with skin thickening, in diffuse and limited cutaneous systemic sclerosis: a retrospective cohort study","volume":"48","author":"Peytrignet","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"2025050316133414800_keae667-B16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/23971983231181719","article-title":"The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosis","volume":"8","author":"Liem","year":"2023","journal-title":"J Scleroderma Relat Disord"},{"key":"2025050316133414800_keae667-B17","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1093\/rheumatology\/kead486","article-title":"Significant gastrointestinal unmet needs in patients with systemic sclerosis: insights from a large international patient survey","volume":"63","author":"Bandini","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2025050316133414800_keae667-B18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41584-020-0386-4","article-title":"Raynaud\u2019s Phenomenon and Digital Ulcers in Systemic Sclerosis","volume":"16","author":"Hughes","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2025050316133414800_keae667-B19","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/rheumatology\/keab850","article-title":"Improvement with time of vascular outcomes in systemic sclerosis: a systematic review and meta-analysis study","volume":"61","author":"Hughes","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025050316133414800_keae667-B20","first-page":"2423","article-title":"Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study","volume":"34","author":"Hachulla","year":"2007","journal-title":"J Rheumatol"},{"key":"2025050316133414800_keae667-B21","first-page":"keae469","article-title":"Distinct clinical trajectories of gastrointestinal progression among patients with systemic sclerosis","author":"Perin","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2025050316133414800_keae667-B22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/rheumatology\/kew047","article-title":"Digital ulcers in systemic sclerosis","volume":"56","author":"Hughes","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2025050316133414800_keae667-B23","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/rheumatology\/keg145","article-title":"A cross-sectional comparison of three self-reported functional indices in scleroderma","volume":"42","author":"Smyth","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"2025050316133414800_keae667-B24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/2397198321999927","article-title":"Impact of Covid-19 on clinical care and lived experience of systemic sclerosis: an international survey from EURORDIS-Rare Diseases Europe","volume":"6","author":"Hughes","year":"2021","journal-title":"J Scleroderma Relat Disord"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae667\/60972182\/keae667.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/5\/2821\/60972182\/keae667.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/5\/2821\/60972182\/keae667.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T20:13:53Z","timestamp":1746303233000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/5\/2821\/7918346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,12,6]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae667","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,12,6]]}}}